Terrence Higgins Trust uses cookies to improve your experience of our websites. For more information or to change the use of cookies, please click here.

Accept and Close

Truvada (emtricitabine + tenofovir disoproxil)


Generic name: emtricitabine (also known as FTC) and tenofovir disoproxil

Brand names: Truvada

Class: Combined NRTI (nukes) tablets


For emtricitabine:

Common: nausea, diarrhoea, headache, raised kinase levels which can cause muscle pain and weakness, skin darkening especially in children, difficulty sleeping, abnormal dreams, dizziness, vomiting, stomach pain, rash, pain.

Rare: anaemia, swelling of the face, lips, tongue or throat.

For tenofovir disoproxil:

Common: Nausea, vomiting, diarrhoea, dizziness, low blood phosphate levels, weakness, rash, headache, stomach pains, fatigue, bloating, flatulence, liver problems.

Rare: Kidney problems, bone thinning, lactic acidosis, pancreatitis, lipodystrophy.


Tablet comprises 200mg emtricitabine and 245mg tenofovir disoproxil.

Take one tablet once a day.


Take with food.

*Last reviewed on 23/09/2015 Next review: 23/09/2018

Any questions? Email feedback@tht.org.uk Information included on this website was correct at the time of publication.

Data and image supplied by NAM.

Further information on this drug from NAM